China develops new COVID-19 vaccine, 'most effective against virus variants'

www.globaltimes.cn
3 min read
difficult
Chinese people are about to embrace a new COVID-19 vaccine, which experts predicted could be the most effective developed in China, as the latest research showed 79 percent efficacy against the dominant Delta variant and overall 67 percent efficacy against any variant.
Photo: A screenshot from the Clover Biopharmaceuticals website

Chinese people are about to embrace a new COVID-19 vaccine, which experts predicted could be the most effective developed in China, as the latest research showed 79 percent efficacy against the dominant Delta variant and overall 67 percent efficacy against any variants.The vaccine, a protein-based COVID-19 vaccine candidate developed by Chengdu-based Clover Biopharmaceuticals, is also the world's first COVID-19 vaccine that has been proven effective against all three mutations (Delta, Gamma and Mu), Zhuang Shilihe, a Guangzhou-based vaccine expert, told the Global Times on Thursday.Clover announced on its website on Wednesday that it had achieved the primary efficacy endpoint and secondary efficacy endpoints in SPECTRA, a global pivotal phase II-III clinical trial.The results showed that the candidate, SCB-2019, demonstrated 79 percent overall efficacy against COVID-19 of any severity caused by the globally dominant Delta variant, which currently comprises more than 90 percent of all cases worldwide.Efficacy was 92 percent against the Gamma variant and 59 percent against the Mu variant, and collectively…
Global Times, Leng Shumei
Read full article